EMAS Position Statements and Clincial Guides
- Worldwide, dyslipidemias are one of the leading causes of cardiovascular disease, mainly coronary heart disease . Dyslipidemias are also associated with an increased risk of ischemic stroke . Dyslipidemias embrace a wide constellation of lipid and lipoprotein abnormalities. Lipoproteins bind lipids and are involved in their transport. Lipid abnormalities include high serum concentrations of low-density lipoprotein (LDL) cholesterol (LDL-C) and/or triglycerides and/or low concentrations of high-density lipoprotein (HDL) cholesterol (HDL-C).
- Diabetes mellitus (DM) is a public health problem, especially in developed countries. It affects about 9.1% of the adult population in Europe and 13.3% in the United States of America . The greater prevalence of DM in developed countries is broadly associated with ageing of the population . Between 2015 and 2030, the world population aged over 60 years is projected to increase by 56%, from 901 million to 1.4 billion; by 2050 it is expected to reach nearly 2.1 billion . These data suggest that the number of postmenopausal women with DM will grow substantially.